These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15509046)

  • 61. Toxoplasmosis in pregnancy and its transmission to the fetus.
    Desmonts G; Couvreur J
    Bull N Y Acad Med; 1974 Feb; 50(2):146-59. PubMed ID: 4521728
    [No Abstract]   [Full Text] [Related]  

  • 62. [Neonatal intoxication with pyrimethamine: risk due to the absence of pediatric formulation?].
    Genuini M; Freihuber C; Girard I; de Montgolfier I; Kieffer F; Mitanchez D
    Arch Pediatr; 2011 Oct; 18(10):1084-6. PubMed ID: 21885264
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Treatment of subclinical congenital toxoplasmosis by sulfadiazine and pyrimethamine continuously during 1 year: apropos of 46 cases].
    Kieffer F; Thulliez P; Brézin A; Nobre R; Romand S; Yi-Gallimard E; Voyer M; Magny JF
    Arch Pediatr; 2002 Jan; 9(1):7-13. PubMed ID: 11865553
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Pancytopenia following pyrimethamine treatment of toxoplasmosis].
    Karsenty J; Gorin NC; Valensi P; Mornet M; Najman A; Duhamel G
    Nouv Presse Med; 1980 Oct; 9(36):2658-60. PubMed ID: 7433060
    [No Abstract]   [Full Text] [Related]  

  • 65. Recurrent congenital toxoplasmosis in a woman with lupus erythematosus.
    D'Ercole C; Boubli L; Franck J; Casta M; Harle JR; Chagnon C; Cravello L; Leclaire M; Blanc B
    Prenat Diagn; 1995 Dec; 15(12):1171-5. PubMed ID: 8750300
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Limitations of prenatal treatment of congenital toxoplasmosis with a sulfadiazine-pyrimethamine combination].
    Boulot P; Pratlong F; Sarda P; Deschamps F; Hedon B; Laffargue F; Viala JL
    Presse Med; 1990 Mar; 19(12):570. PubMed ID: 2139220
    [No Abstract]   [Full Text] [Related]  

  • 67. Serologic rebounds after one-year-long treatment for congenital toxoplasmosis.
    Djurkovic-Djakovic O; Romand S; Nobrè R; Couvreur J; Thulliez P
    Pediatr Infect Dis J; 2000 Jan; 19(1):81-3. PubMed ID: 10643858
    [No Abstract]   [Full Text] [Related]  

  • 68. Congenital Toxoplasmosis in Tunisia: Prenatal and Neonatal Diagnosis and Postnatal Follow-up of 35 Cases.
    Boudaouara Y; Aoun K; Maatoug R; Souissi O; Bouratbine A; Abdallah RB
    Am J Trop Med Hyg; 2018 Jun; 98(6):1722-1726. PubMed ID: 29663900
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prophylaxis of toxoplasmosis infection with pyrimethamine/sulfadoxine (Fansidar) in bone marrow transplant recipients.
    Foot AB; Garin YJ; Ribaud P; Devergie A; Derouin F; Gluckman E
    Bone Marrow Transplant; 1994 Aug; 14(2):241-5. PubMed ID: 7994239
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Fansidar in the treatment of toxoplasmosis].
    Michalová K; Ríhová E; Havlíková M
    Cesk Slov Oftalmol; 1996 Jul; 52(3):173-8. PubMed ID: 8768475
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Congenital Toxoplasmosis.
    Guha R; Miley L; Aspiri M; Dhamija R
    Pediatr Neurol; 2017 May; 70():81-82. PubMed ID: 28254246
    [No Abstract]   [Full Text] [Related]  

  • 72. Stevens-Johnson Syndrome During Pregnancy: Case Report of a Newborn Treated With the Culprit Drug.
    Velter C; Hotz C; Ingen-Housz-Oro S; Wolkenstein P; Fardet L
    JAMA Dermatol; 2018 Feb; 154(2):224-225. PubMed ID: 29261833
    [No Abstract]   [Full Text] [Related]  

  • 73. [Treatment of congenital toxoplasmosis].
    Couvreur J; Desmonts C
    Zentralbl Gynakol; 1983; 105(17):1108-12. PubMed ID: 6650002
    [No Abstract]   [Full Text] [Related]  

  • 74. [Pharmacovigilance and impact of intermittent preventive treatment with sulfadoxine-pyrimethamine in pregnant women in Sélingué, Mali].
    Maiga AS; Diakite M; Diawara A; Sango HA; Coulibaly CO
    Mali Med; 2010; 25(3):41-8. PubMed ID: 21441083
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Therapeutic approaches for AIDS-related toxoplasmosis.
    Behbahani R; Moshfeghi M; Baxter JD
    Ann Pharmacother; 1995; 29(7-8):760-8. PubMed ID: 8520094
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Azithromycin reduces ocular infection during congenital transmission of toxoplasmosis in the Calomys callosus model.
    Lopes CD; Silva NM; Ferro EA; Sousa RA; Firminot ML; Bernardes ES; Roque-Barreira MC; Pena JD
    J Parasitol; 2009 Aug; 95(4):1005-10. PubMed ID: 20050006
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Simultaneous determination of pyrimethamine, sulfadiazine and N-acetyl-sulfadiazine in plasma for monitoring infants in treatment of congenital toxoplasmosis.
    Johannessen JK; Christiansen I; Schmidt DR; Petersen E; Hansen SH
    J Pharm Biomed Anal; 2005 Jan; 36(5):1093-8. PubMed ID: 15620537
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Toxoplasmosis: diagnosis, treatment, and prevention in congenitally exposed infants.
    Kaye A
    J Pediatr Health Care; 2011; 25(6):355-64. PubMed ID: 22018426
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039.
    Chirgwin K; Hafner R; Leport C; Remington J; Andersen J; Bosler EM; Roque C; Rajicic N; McAuliffe V; Morlat P; Jayaweera DT; Vilde JL; Luft BJ
    Clin Infect Dis; 2002 May; 34(9):1243-50. PubMed ID: 11941551
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Management of Toxoplasmic Seroconversion in the Third Trimester of Pregnancy in Tunisia].
    Bouhlel S; Ben Abdallah R; Aoun K; Maatoug R; Souissi O; Bouratbine A
    Bull Soc Pathol Exot; 2018; 111(5):269-274. PubMed ID: 30950590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.